BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30257110)

  • 1. The impact of portal vein thrombosis on the prognosis and liver function of nonmalignant cirrhotic patients.
    Endo K; Oikawa T; Kakisaka K; Tamura A; Ehara S; Takikawa Y
    Scand J Gastroenterol; 2018; 53(10-11):1340-1346. PubMed ID: 30257110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study.
    Gao B; Xiao J; Zhang M; Zhang F; Zhang W; Yang J; He J; Liu Y; Zou X; Xu P; Zhuge Y
    Lipids Health Dis; 2019 Mar; 18(1):79. PubMed ID: 30927926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the Model for End-stage Liver Disease scoring system.
    Abdel-Razik A; Mousa N; Elhelaly R; Tawfik A
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):585-92. PubMed ID: 25769098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis.
    Chung JW; Kim GH; Lee JH; Ok KS; Jang ES; Jeong SH; Kim JW
    Clin Mol Hepatol; 2014 Dec; 20(4):384-91. PubMed ID: 25548745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein thrombosis in patients with cirrhosis: just a common finding or a predictor of poor outcome?
    Borjas-Almaguer OD; Cortez-Hernández CA; González-Moreno EI; Bosques-Padilla FJ; González-González JA; Garza AA; Martínez-Segura JA; García-Compean D; Alejandre-Loya JV; García-García J; Delgado-García G; Maldonado-Garza HJ
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):902-906. PubMed ID: 27740524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
    Zhou H; Wu M; Yu S; Xia H; Yu W; Huang K; Chen Y
    BMC Gastroenterol; 2023 Sep; 23(1):329. PubMed ID: 37749527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver.
    Rosenqvist K; Eriksson LG; Rorsman F; Sangfelt P; Nyman R
    Acta Radiol; 2016 May; 57(5):572-9. PubMed ID: 26253926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.
    Zocco MA; Di Stasio E; De Cristofaro R; Novi M; Ainora ME; Ponziani F; Riccardi L; Lancellotti S; Santoliquido A; Flore R; Pompili M; Rapaccini GL; Tondi P; Gasbarrini GB; Landolfi R; Gasbarrini A
    J Hepatol; 2009 Oct; 51(4):682-9. PubMed ID: 19464747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and clinical presentation of portal vein thrombosis in cirrhotic patients.
    Cagin YF; Atayan Y; Erdogan MA; Dagtekin F; Colak C
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):499-503. PubMed ID: 27733319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.
    Khoury T; Massarwa M; Hazou W; Daher S; Hakimian D; Benson AA; Ashqar T; Mahamid M; Yaari S
    J Gastrointest Cancer; 2019 Dec; 50(4):759-762. PubMed ID: 30043228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis.
    Kukla M; Waluga M; Żorniak M; Berdowska A; Wosiewicz P; Sawczyn T; Bułdak RJ; Ochman M; Ziora K; Krzemiński T; Hartleb M
    World J Gastroenterol; 2017 Apr; 23(14):2613-2624. PubMed ID: 28465646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
    Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
    Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.
    Merola J; Fortune BE; Deng Y; Ciarleglio M; Amirbekian S; Chaudhary N; Shanbhogue A; Ayyagari R; Rodriguez-Davalos MI; Teperman L; Charles HW; Sigal SH
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):668-675. PubMed ID: 29462027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Portal Vein Thrombosis on Liver Transplant Outcomes: Does Grade or Flow Rate Matter?
    Rizzari MD; Safwan M; Sobolic M; Kitajima T; Collins K; Yoshida A; Abouljoud M; Nagai S
    Transplantation; 2021 Feb; 105(2):363-371. PubMed ID: 32217946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural course of nonmalignant partial portal vein thrombosis in cirrhotic patients.
    Girleanu I; Stanciu C; Cojocariu C; Boiculese L; Singeap AM; Trifan A
    Saudi J Gastroenterol; 2014; 20(5):288-92. PubMed ID: 25253363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.
    Ghabril M; Agarwal S; Lacerda M; Chalasani N; Kwo P; Tector AJ
    Transplantation; 2016 Jan; 100(1):126-33. PubMed ID: 26050013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study.
    Lancellotti S; Basso M; Veca V; Sacco M; Riccardi L; Pompili M; De Cristofaro R
    Intern Emerg Med; 2016 Oct; 11(7):959-67. PubMed ID: 27220954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.